Skip to Main Content

Paper Details

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis.
Cancer Med
14
2021
Author NameAffiliation
Nicholas MitsakakisInstitute of Health Policy, Dalla Lana School of Public Health, University of Toronto
  • 1 - 1

Datasets

Release 1.2